IP Library Assignment 059654/0637
Patent Assignment
Reel/Frame 059654/0637

Assignment of Assignor's Interest

Recorded: 2022-04-20 Pages: 10
Assignors
ELLIOTT, BRIAN
Executed: 2022-02-23
AHMADI, TAHAMTAN
Executed: 2022-04-12
CHIU, CHRISTOPHER W. L.
Executed: 2022-02-03
BREIJ, ESTHER C. W
Executed: 2022-03-10
HIEMSTRA, IDA
Executed: 2022-02-07
JURE-KUNKEL, MARIA N.
Executed: 2022-02-16
Assignee
GENMAB A/S
KALVEBOD BRYGGE 43, COPENHAGEN V, DK-1560, DENMARK
Covered Properties (2)
Bispecific Antibody Against CD3 and CD20 in Combination Therapy for Treating Diffuse Large B-Cell Lymphoma
Application: 17/558,430 →
Publication: US 2022/0119544
Bispecific Antibody Against CD3 and CD20 in Combination Therapy for Treating Diffuse Large B-Cell Lymphoma
Application: 17/472,045 →
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Dec 15, 2025
From: GENMAB A/S; GENMAB B.V.; GENMAB HOLDING B.V.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 073933/0597 →
Notice of Grant of Security Interest in Patents Dec 15, 2025
From: GENMAB A/S; GENMAB B.V.; GENMAB HOLDING B.V.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 073949/0722 →